Kura Oncology, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
50.23 |
138.32 |
206.05 |
290.10 |
525.91 |
785.30 |
| Przychód Δ r/r |
0.00% |
175.36% |
48.96% |
40.79% |
81.29% |
49.32% |
| Przychód (min) |
7.28 |
3.05 |
20.25 |
287.62 |
35.63 |
53.21 |
| Przychód (max) |
87.37 |
335.58 |
455.72 |
292.57 |
1,208.30 |
1,804.25 |
| EBITDA (średnia) |
30.14 |
82.99 |
123.63 |
174.06 |
315.55 |
471.18 |
| EBIT (średnia) |
30.14 |
82.99 |
123.63 |
174.06 |
315.55 |
471.18 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-205.51 |
-157.32 |
-157.92 |
-145.12 |
-38.50 |
121.65 |
| Zysk netto % |
-409.10% |
-113.73% |
-76.64% |
-50.03% |
-7.32% |
15.49% |
| EPS (średnia) |
-2.45 |
-1.83 |
-1.91 |
-1.70 |
-0.45 |
1.41 |
| Liczba analityków (Przychody) |
10 |
9 |
14 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
10 |
9 |
11 |
11 |
5 |
4 |
| symbol |
KURA |
KURA |
KURA |
KURA |
KURA |
KURA |